H.R. 586 (119th)Bill Overview

Vietnam Veterans Liver Fluke Cancer Study Act

Armed Forces and National Security|Armed Forces and National SecurityAsia
Cosponsors
Support
Bipartisan
Introduced
Jan 21, 2025
Discussions
Bill Text
Current stageCommittee

Received in the Senate and Read twice and referred to the Committee on Veterans' Affairs.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill directs the Secretary of Veterans Affairs, in consultation with the CDC director, to begin an epidemiological study of cholangiocarcinoma (bile duct cancer) prevalence among veterans who served in the Vietnam theater. The study must use the VA Central Cancer Registry and National Program of Cancer Registries, compare incidence with U.S. residents, report demographic and geographic breakdowns, and produce an initial report to Congress with recommendations.

Why people may split

Liberals emphasize pathway to benefits and justice for veterans

Watch point

Relative to its intended legislative type, this bill is a clearly focused study-and-report measure that correctly assigns responsibility and identifies data sources and reporting recipients, but it omits key methodological, resourcing, and operational details required for fully executable epidemiological research.

The bill directs the Secretary of Veterans Affairs, in consultation with the CDC director, to begin an epidemiological study of cholangiocarcinoma (bile duct cancer) prevalence among veterans who served in the Vietnam theater.

The study must use the VA Central Cancer Registry and National Program of Cancer Registries, compare incidence with U.S. residents, report demographic and geographic breakdowns, and produce an initial report to Congress with recommendations.

The VA must continue tracking cases and provide periodic follow-up reports.

Passage80/100

Narrow, noncontroversial health surveillance bill with limited cost exposure and clear implementability makes enactment relatively likely absent procedural blockers.

CredibilityPartially aligned

Relative to its intended legislative type, this bill is a clearly focused study-and-report measure that correctly assigns responsibility and identifies data sources and reporting recipients, but it omits key methodological, resourcing, and operational details required for fully executable epidemiological research.

Contention48/100

Liberals emphasize pathway to benefits and justice for veterans

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
VeteransFederal agencies

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • VeteransProvides epidemiological evidence to assess higher cholangiocarcinoma rates among Vietnam-era veterans.
  • Potential benefitCould support expanded VA benefits presumptions if elevated incidence is found.
  • VeteransEnables targeted screening and clinical follow-up for at-risk veterans, potentially improving outcomes.
Likely burdened
  • Potential burdenStudy and ongoing tracking will increase VA administrative and research costs.
  • Federal agenciesFindings could lead to expanded compensation liabilities and higher federal spending.
  • Potential burdenPrivacy or data-sharing concerns may arise from registry linkage across agencies.
03 · Why people split

Why the argument around this bill splits.

Liberals emphasize pathway to benefits and justice for veterans
Progressive90%

Generally supportive: views the study as a data-driven step toward recognizing and addressing possible service-related cancers among Vietnam veterans.

Sees potential pathway to improved care, benefits, and outreach if results show elevated incidence.

Leans supportive
Centrist75%

Cautiously supportive: welcomes an evidence-based epidemiological study while wanting clear timelines, methodology, and funding.

Sees merit in CDC involvement but expects safeguards against duplication and unclear costs.

Leans supportive
Conservative40%

Skeptical but not uniformly opposed: supports veteran health monitoring in principle, yet worries about cost, federal overreach, and creating pressure for expanded VA benefit liabilities.

Prefers limited scope and fiscal constraints.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood80/100

Narrow, noncontroversial health surveillance bill with limited cost exposure and clear implementability makes enactment relatively likely absent procedural blockers.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • No formal cost estimate or appropriation language included
  • Timing ambiguity around ‘completion of the study’ and report deadlines
05 · Recent votes

Recent votes on the bill.

HOUSE · Apr 7, 2025
Fast-track passage✓ PassedBipartisanNear-unanimous
2/3 majority required

The House fast-tracked this bill — skipping normal debate — and it passed with a two-thirds majority. It now moves to the Senate.

What is a fast-track passage?

Suspending the rules allows the House to bypass normal debate procedures and pass a bill immediately with a two-thirds vote.

Yes 100% No 0%
Showing a quick cross-section of legislators, with followed members first when available.
06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals emphasize pathway to benefits and justice for veterans

Narrow, noncontroversial health surveillance bill with limited cost exposure and clear implementability makes enactment relatively likely a…

Unlocked analysis

Relative to its intended legislative type, this bill is a clearly focused study-and-report measure that correctly assigns responsibility and identifies data sources and reporting recipients, but it omits key methodologi…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis